Mission GBM
Subscribe
Sign in
Home
Archive
About
New
Top
Immuno-Oncology: A Question of Balance
A SARS-CoV-2 infection precipitates a cascading series of immunological adverse events
Apr 15
•
Scott L. Rakestraw, PhD
9
Share this post
Immuno-Oncology: A Question of Balance
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
February 2023
Results That Matter
Team Julie delivers a remarkable outcome based on leading edge clinical science
Feb 2
•
Scott L. Rakestraw, PhD
14
Share this post
Results That Matter
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
January 2023
The Central Hypothesis of Immunotherapy and Its Application to Brain Cancer
Rapid advances raise the bar on what can be achieved for patients
Jan 30
•
Scott L. Rakestraw, PhD
2
Share this post
The Central Hypothesis of Immunotherapy and Its Application to Brain Cancer
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
A Year in the Life
Charting the journey over 365 days of living with GBM
Jan 19
•
Scott L. Rakestraw, PhD
14
Share this post
A Year in the Life
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
Day One Biopharmaceuticals Announces Top Line Data for the FIREFLY-1 Pivotal Phase 2 Trial in Pediatric Low Grade Glioma
Meaningful clinical responses to tovorafenib suggest an important new tool in the Brain Cancer Toolbox
Jan 12
•
Scott L. Rakestraw, PhD
2
Share this post
Day One Biopharmaceuticals Announces Top Line Data for the FIREFLY-1 Pivotal Phase 2 Trial in Pediatric Low Grade Glioma
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
Stanford's Innovative Medicines Accelerator and The Invus Group Collaborate to Attack GBM
An important and visionary partnership featuring multiple members of Team Julie
Jan 10
•
Scott L. Rakestraw, PhD
4
Share this post
Stanford's Innovative Medicines Accelerator and The Invus Group Collaborate to Attack GBM
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
December 2022
Meet the Team: David W. Andrews, MD
Neurosurgeon "par excellence" and Biotech entrepreneur
Dec 27, 2022
•
Scott L. Rakestraw, PhD
5
Share this post
Meet the Team: David W. Andrews, MD
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
Meet the Team: Michael L. Dougan, MD, PhD
Optimizing Immuno-Oncology treatment by overcoming immune-related Adverse Events (irAEs)
Dec 21, 2022
•
Scott L. Rakestraw, PhD
4
Share this post
Meet the Team: Michael L. Dougan, MD, PhD
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
One Year Later: A Winter Celebration
We travel to the wedding of a dear friend's daughter in snowy Vermont
Dec 19, 2022
•
Scott L. Rakestraw, PhD
15
Share this post
One Year Later: A Winter Celebration
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
Big News: Moderna and Merck Report Phase 2b Data for an mRNA Cancer Vaccine + Pembrolizumab
Further Evidence that the Central Hypothesis is gaining traction in cancer immunotherapy
Dec 14, 2022
•
Scott L. Rakestraw, PhD
4
Share this post
Big News: Moderna and Merck Report Phase 2b Data for an mRNA Cancer Vaccine + Pembrolizumab
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
Podcast: The Role of T-Lymphocytes in Glioma Pathobiology
Dr. Iyad Alnahhas (Jefferson University Neuro-Oncology) interviews pediatric brain cancer pioneer Dr. David Gutmann (Washington University - St. Louis…
Dec 7, 2022
•
Scott L. Rakestraw, PhD
3
Share this post
Podcast: The Role of T-Lymphocytes in Glioma Pathobiology
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
Meet the Team: David D. Tran, MD, PhD
Chief of Neuro-Oncology, Keck Medicine of USC; Co-Director of the USC Brain Tumor Center
Dec 5, 2022
•
Scott L. Rakestraw, PhD
9
Share this post
Meet the Team: David D. Tran, MD, PhD
www.missiongbm.com
Copy link
Twitter
Facebook
Email
Notes
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
